A research article entitled "Design and Evaluation of an Automated Pediatric Acute Lymphoblastic Leukemia Registry from Clinical Data Warehouses" has been published in BMC Medical Informatics and Decision Making (2026). BMC Medical Informatics and Decision Making is a leading international journal that publishes high-impact research on the development, implementation, and evaluation of medical informatics, clinical decision-making systems, and health information technologies. Our study presents a comprehensive framework for constructing a high-quality, scalable pediatric acute lymphoblastic leukemia (ALL) registry through automated extraction of electronic medical record (EMR)-based real-world data (RWD) from clinical data warehouses (CDWs).

The study developed PeARL (Pediatric ALL Registry using eLectronic medical record-based RWD) by integrating standardized mapping, multivariate transformations, and rule-based natural language processing (NLP) to capture clinically relevant variables from two university-affiliated tertiary-care hospitals in South Korea: Seoul National University Hospital (SNUH) and the Catholic Medical Center (CMC). A total of 1,609 pediatric patients with ALL (663 from SNUH and 946 from CMC) were included. Data quality was systematically evaluated using 228 rules across five dimensions (completeness, validity, accuracy, uniqueness, consistency).

The results showed that the automated data extraction proportion reached 89.7% at SNUH and 75.0% at CMC, with most elements processed through single-field transformations. After applying the quality management process, the overall error rate decreased from 1.858% to 0.001% at SNUH and from 0.129% to 0.001% at CMC, corresponding to an estimated reliability of 99%. Moreover, the registry demonstrated robust multicenter applicability through standardized table specifications and cross-site review, despite structural differences between institutional CDWs.

Overall, the study highlights the potential of a clinically guided, standardized framework as a reproducible and scalable solution for registry construction. By combining structured mapping, multivariate transformation, and rule-based NLP, the proposed approach offers a practical pathway for multicenter research and regulatory-grade real-world evidence generation.

A new research article, entitled “Assessing the representativeness of single-center EMR data on ten cancer types: A comparative analysis with national statistics from South Korea (2011–2021)”, authored by Won Jung-Hyun and Howard Lee, was published in the International Journal of Medical Informatics(IJMI). IJMI is a leading international journal that publishes high-impact research on the development, implementation, and real-world evaluation of health information systems and clinical informatics technologies.

This study evaluated whether single-center electronic medical record (EMR) data from Seoul National University Hospital (SNUH) could represent a real-world data source for oncology research in South Korea. To address this, the study analyzed annual incidence and prevalence patterns for ten major cancer types (e.g., breast, gallbladder/biliary tract, gastric, kidney, liver, lung, pancreatic, prostate, thyroid cancers, and leukemia) from 2011 to 2021 using national cancer statistics from the Korean Statistical Information Service (KOSIS) as reference. The study also examined age and gender distributions between two datasets. The results showed that the SNUH EMR data included 8.2% of national incident cancer cases and 10.7% of prevalent cases. The study also found no significant differences in age and gender distributions across all cancer types between the SNUH EMR and national data. In addition, strong correlations in annual trends were observed for several major cancers, including breast, lung, and pancreatic cancers. Overall, this study showed that single-center EMR data can be a valuable, representative clinical resource for oncology research in South Korea. At the same time, the study emphasizes that the underrepresentation of certain cancer types and external temporal factors, such as changes in clinical guidelines or major healthcare disruptions, should be carefully considered when generalizing findings from a single institution to broader populations.

The research article entitled “Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real-World Data: A Retrospective Observational Study”¹, which was first-authored by the former CCADD graduate,Yoona Choi, and co-authored by the members of CCADD  has been cited in the lastest haematology guidelines on the diagnosis and managemet of tumour lysis syndrome² published by the British Society for Haematology. Moreover, the study was cited in a recent review article published in the New England Journal of Medicine (NEJM)³ detailing the epidemiology and pathophysiology of tumor lysis syndrome.

The British Society for Haematology produces up-to-date evidence-based guidelines on the diagnosis and treatment of haematological disease, while The New England Journal of Medicine is one of the prominent journals of new medical knowledge and clinical best practicies worldwide (Impact Factor 78.5).

This recognition highlights the clinical significance of our study in advancing evidence-based practice for pediatric acute lymphoblastic leukemia. CCADD takes pride in producing research that informs medical decision-making, and will continue efforts to deliver impactful studies.

1_Choi Y, Kim BK, Won JH, Yoo JW, Choi W, Jung S, Kim JY, Choi IY, Chung NG, Lee JW, Choi JY, Kang HJ, Lee H. Prephase steroid treatment before remission induction chemotherapy in patients with pediatric acute lymphoblastic leukemia using common data model-based real-world data: a retrospective observational study. Clin Epidemiol. 2024 Apr 22;16:293-304. doi:10.2147/CLEP.S454263. PMID:38681782; PMCID:PMC11049150.

2_Chan YLT, El-Sharkawi D, Shah P, Chanouzas D, O’Connor D, Marks SD, et al. British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological malignancies: a focus on patient safety. Br J Haematol. 2025;00:1-11. doi:10.1111/bjh.70092.

3_Bociek RG, Lunning M. Tumor lysis syndrome. N Engl J Med. 2025 Sep 18;393(11):1104-1116. doi:10.1056/NEJMra2300923. PMID:40961427.

Choi Y, Kim BK, Won JH, Yoo JW, Choi W, Jung S, Kim JY, Choi IY, Chung NG, Lee JW, Choi JY, Kang HJ, Lee H. A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real-World Data: A Retrospective Observational Study. Clin Epidemiol. 2024 Apr 22;16:293-304. doi: 10.2147/CLEP.S454263. PMID: 38681782; PMCID: PMC11049150.